Seoul trader: AstraZeneca’s $74 million Korea move
This article was originally published in Scrip
Executive Summary
AstraZeneca may have its fair share of R&D partnerships with other companies, but a new alliance will see the UK group invest Won80 billion ($73.7 million) over the next five years in a series of collaborative projects with South Korea's ministry of health.